| Dr Robert Adelman, MD | |
|
21601 76th Ave W, Edmonds, WA 98026-7507 | |
| (425) 640-4682 | |
| (425) 640-4105 |
| Full Name | Dr Robert Adelman |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 21601 76th Ave W, Edmonds, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376585414 | NPI | - | NPPES |
| 1005156 | Medicaid | WA | |
| AD3008 | Other | REGENCE BS | |
| A09303 | Other | GROUP HEALTH COOP | |
| A006 | Other | CHAMPUS | |
| 168563 | Other | WA L & I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 000-16972 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Adelman, MD Po Box 34936, Dept 3028, Seattle, WA 98124-1936 Ph: (888) 398-2473 | Dr Robert Adelman, MD 21601 76th Ave W, Edmonds, WA 98026-7507 Ph: (425) 640-4682 |
News Archive
Having now reached its third year, Project "iHEART" of Politecnico di Milano, winner of an ERC Advanced Grant of euro 2,350,000, has set itself the ambitious goal of creating a complete mathematical model to study the behavior of the human heart and of its pathologies, a sort of "virtual microscope."
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2012 (1Q12) of $1.49, compared to $1.86 per share for the quarter ended March 31, 2011 (1Q11). The company had previously anticipated earnings per share in the range of $1.35 to $1.45 for 1Q12.
UC San Francisco researchers studying beige fat — a calorie-burning tissue that can help to ward off obesity and diabetes — have discovered a new strategy to cultivate this beneficial blubber.
A promising but expensive device to prop open blocked arteries in the brain in the hope of preventing disabling or fatal strokes failed in a rigorous study, researchers reported on Wednesday. Those who got the device actually had so many more strokes than those assigned to control risk factors, like blood pressure, cholesterol and diabetes, that the study was abruptly terminated.
TWi Pharmaceuticals, Inc., a specialty pharmaceutical company based in Taiwan, today announced its fully owned subsidiary, TWi Biotechnology, Inc. has completed a multinational phase II dose-ranging study of AC-201, an orally available IL-1 Beta modulator, in 259 patients with type II diabetes uncontrolled on up to three oral medications.
› Verified 2 days ago
Dr. Bryce Curtis Inman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 | |
Dr. Raul Borromeo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4100 | |
Katherine Bryant, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4682 | |
Dr. Robert Rutherford, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4682 | |
Mr. Thomas James Swanson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 | |
Dr. Joshua James Faucher, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 |